期刊
PROSTATE CANCER AND PROSTATIC DISEASES
卷 9, 期 3, 页码 275-278出版社
SPRINGERNATURE
DOI: 10.1038/sj.pcan.4500891
关键词
prostate cancer; hot flashes; paroxetine; serotonin uptake inhibitors
Purpose: Hot flash (HF) is a common side effect in prostate cancer patient undergoing androgen-deprivation therapy (ADT). In this study, we evaluated the efficacy of paroxetine ( selective serotonin reuptake inhibitors (SSRIs)) for HF. Patients and methods: In total, 10 men with prostate cancer under ADH who were suffering with HF entered this study. Self-report questionnaire was used for the evaluation. Results: The average rating for HF frequency decreased ( P = 0.009) and HF severity decreased ( P = 0.0332) also, reported QOL score increased ( P = 0.0218). Conclusion: These preliminary data suggest that low dose ( 10 mg/day) of antidepressant paroxetine can be helpful in the treatment of HFs in patients under ADT for prostate cancer. Further controlled studies are needed to more fully evaluate the efficacy of the SSRIs.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据